{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:53:14Z","timestamp":1791262394790,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis Imaging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ostima.2026.100475","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:23:07Z","timestamp":1790896987000},"page":"100475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perspective: Mesenchymal stromal cells and PRP in osteoarthritis: Hope, hype and the hard evidence"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3197-752X","authenticated-orcid":false,"given":"David","family":"Hunter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0227-9776","authenticated-orcid":false,"given":"DingYuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ostima.2026.100475_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-025-00594-6","article-title":"Osteoarthritis","volume":"11","author":"Tang","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ostima.2026.100475_bib0002","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/jcm14062061","article-title":"Advancements in regenerative therapies for orthopedics: a comprehensive review of platelet-rich plasma, mesenchymal stem cells, peptide therapies, and biomimetic applications","volume":"14","author":"Goulian","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ostima.2026.100475_bib0003","doi-asserted-by":"crossref","first-page":"9149","DOI":"10.3390\/ijms25179149","article-title":"Mesenchymal stem cell-derived exosomes as a treatment option for osteoarthritis","volume":"25","author":"Vadhan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ostima.2026.100475_bib0004","first-page":"1","article-title":"The effectiveness and safety of mesenchymal stem cells in the treatment of osteoarthritis: a systematic review and meta-analysis of 28 randomized controlled trials","volume":"2022","author":"Long","year":"2022","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.ostima.2026.100475_bib0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13287-025-04252-2","article-title":"Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Cao","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ostima.2026.100475_bib0006","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1038\/s41591-023-02632-w","article-title":"Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial","volume":"29","author":"Mautner","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ostima.2026.100475_bib0007","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-023-03332-5","article-title":"A systematic review, umbrella review, and quality assessment on clinical translation of stem cell therapy for knee osteoarthritis: are we there yet?","volume":"14","author":"Shang","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ostima.2026.100475_bib0008","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ostima.2026.100475_bib0009","article-title":"2026 update of the American college of rheumatology recommendations for the management of osteoarthritis of the knee","year":"2026","journal-title":"Hip Hand"},{"key":"10.1016\/j.ostima.2026.100475_bib0010","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1177\/03635465241274155","article-title":"Evaluation of spin in clinical trials of mesenchymal stromal cells for the treatment of knee osteoarthritis: a systematic review","volume":"53","author":"Woolley","year":"2025","journal-title":"Am. J. Sports Med."},{"key":"10.1016\/j.ostima.2026.100475_bib0011","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/15563316231200496","article-title":"How well do studies of mesenchymal stem cell intervention and knee osteoarthritis adhere to the minimum information for studies evaluating biologics guidelines? A systematic review of randomized controlled trials","volume":"20","author":"Abed","year":"2024","journal-title":"HSS J."},{"key":"10.1016\/j.ostima.2026.100475_bib0012","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1001\/jama.2021.19415","article-title":"Effect of intra-articular platelet-rich plasma vs Placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE randomized clinical trial","volume":"326","author":"Bennell","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ostima.2026.100475_bib0013","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/03635465211062243","article-title":"How does platelet-rich plasma compare clinically to other therapies in the treatment of knee osteoarthritis? A systematic review and meta-analysis","volume":"51","author":"Costa","year":"2023","journal-title":"Am. J. Sports Med."},{"key":"10.1016\/j.ostima.2026.100475_bib0014","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.arthro.2023.03.001","article-title":"Patients with knee osteoarthritis who receive platelet-rich plasma or bone marrow aspirate concentrate injections have better outcomes than Patients who receive hyaluronic acid: systematic review and meta-analysis","volume":"39","author":"Belk","year":"2023","journal-title":"Arthrosc.: J. Arthrosc. Relat. Surg."},{"key":"10.1016\/j.ostima.2026.100475_bib0015","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.arthro.2024.01.037","volume":"40","author":"Jawanda","year":"2024","journal-title":"Arthroscopy"},{"key":"10.1016\/j.ostima.2026.100475_bib0018","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/arj.70027","article-title":"Statistically significant results favored in abstracts of platelet rich plasma treatment of knee osteoarthritis: a systematic review and spin analysis","volume":"42","author":"Fullano","year":"2026","journal-title":"Arthroscopy"},{"key":"10.1016\/j.ostima.2026.100475_bib0019","doi-asserted-by":"crossref","DOI":"10.1007\/s00590-025-04353-x","article-title":"Spin and reporting bias in the use of platelet-rich plasma for the treatment of knee osteoarthritis","volume":"35","author":"Richardson","year":"2025","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"10.1016\/j.ostima.2026.100475_bib0020","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1177\/03635465231185289","article-title":"Randomized controlled trials on platelet-rich plasma for knee osteoarthritis poorly adhere to the minimum information for studies evaluating biologics in orthopaedics (MIBO) Guidelines: A systematic review","volume":"52","author":"Stone","year":"2024","journal-title":"Am. J. Sports Med."},{"key":"10.1016\/j.ostima.2026.100475_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-056382","article-title":"Efficacy and cost-effectiveness of Stem Cell injections for symptomatic relief and strUctural improvement in people with tibiofemoral knee OsteoaRthritis: protocol for a randomised placebo-controlled trial (the SCUlpTOR trial)","volume":"11","author":"Liu","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ostima.2026.100475_bib0028","unstructured":"Study details | NCT05526001 | efficacy and safety of ELIXCYTE intra-articular injection in subject with knee osteoarthritis | ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/study\/NCT05526001 (accessed June 16, 2026)."},{"key":"10.1016\/j.ostima.2026.100475_bib0029","unstructured":"Study details | NCT03291470 | Study to determine the efficacy and safety of TG-C in subjects with Kellgren\/Lawrence grade 2 or 3 OA of the knee | ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/study\/NCT03291470? (accessed June 16, 2026)."},{"key":"10.1016\/j.ostima.2026.100475_bib0016","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.5435\/JAAOS-D-21-01233","article-title":"AAOS Clinical Practice Guideline Summary: management of osteoarthritis of the knee (Nonarthroplasty), third edition","volume":"30","author":"Brophy","year":"2022","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"10.1016\/j.ostima.2026.100475_bib0017","unstructured":"Overview | Platelet-rich plasma injections for knee osteoarthritis | Guidance | NICE n.d."},{"key":"10.1016\/j.ostima.2026.100475_bib0021","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/CORR.0000000000002864","article-title":"There is wide variation in platelet-rich plasma injection pricing: A United States nationwide study of top orthopaedic hospitals","volume":"482","author":"Tiao","year":"2024","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.ostima.2026.100475_bib0022","unstructured":"Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes | FDA n.d. https:\/\/www.fda.gov\/vaccines-blood-biologics\/consumers-biologics\/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes (accessed June 15, 2026)."},{"key":"10.1016\/j.ostima.2026.100475_bib0023","unstructured":"Statutes of the Republic of Korea n.d. https:\/\/elaw.klri.re.kr\/eng_service\/lawTwoView.do?hseq=60777 (accessed September 23, 2026)."},{"key":"10.1016\/j.ostima.2026.100475_bib0024","unstructured":"National Institute of Health|support activities|service|Advanced Regenerative Medicine Safety Management n.d. https:\/\/nih.go.kr\/eng\/main\/contents.do?menuNo=200059 (accessed September 23, 2026)."},{"key":"10.1016\/j.ostima.2026.100475_bib0025","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.stem.2021.10.008","article-title":"The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions","volume":"28","author":"Turner","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ostima.2026.100475_bib0026","unstructured":"Florida Is Now a Haven for Unproven Stem-Cell Treatments | WIRED n.d. https:\/\/www.wired.com\/story\/florida-is-now-a-haven-for-unproven-stem-cell-treatments\/(accessed June 15, 2026)."}],"container-title":["Osteoarthritis Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772654126000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772654126000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:22:02Z","timestamp":1791260522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772654126000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"alternative-id":["S2772654126000851"],"URL":"https:\/\/doi.org\/10.1016\/j.ostima.2026.100475","relation":{},"ISSN":["2772-6541"],"issn-type":[{"value":"2772-6541","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspective: Mesenchymal stromal cells and PRP in osteoarthritis: Hope, hype and the hard evidence","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ostima.2026.100475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society of Osteoarthritis Imaging.","name":"copyright","label":"Copyright"}],"article-number":"100475"}}